NHSScotland should note that:
1. Recommendations of NICE Single Technology Appraisals (STAs) have no status in NHS Scotland.
2. NHS Boards should continue to adhere to the SMC advice.
3. The Scottish Medicines Consortium (SMC) published a Statement of Advice on this medication for this indication in July 2008. This stated that:
Tenofovir disoproxil (Viread®) is accepted for use within NHS Scotland for the treatment of chronic hepatitis B in adults with compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis.
Access the advice of the Scottish Medicines Consortium: http://www.scottishmedicines.org.uk/smc/5778.html
